Notch pathway promotes ovarian cancer growth and migration via CXCR4/SDF1α chemokine system

International Journal of Biochemistry and Cell Biology

Volumn 66, Issue , 2015, Pages 134-140

  Chiaramonte, R ^a   Colombo, M ^a   Bulfamante, G ^a   Falleni, M ^a   Tosi, D ^a   Garavelli, S ^a   De Simone, D ^a   Vigolo, E ^a   Todoerti, K ^b   Neri, A ^a   Platonova, N ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Cell growth; CXCR4; Migration; Notch pathway; Ovarian cancer; SDF1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GAMMA SECRETASE INHIBITOR; NOTCH1 RECEPTOR; STROMAL CELL DERIVED FACTOR 1BETA; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CXCR4 PROTEIN, HUMAN; DIPEPTIDE; HES6 PROTEIN, HUMAN; N-(N-(3,5-DIFLUOROPHENACETYL)ALANYL)PHENYLGLYCINE TERT-BUTYL ESTER; NOTCH1 PROTEIN, HUMAN; REPRESSOR PROTEIN; SECRETASE; STROMAL CELL DERIVED FACTOR 1;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CELL VIABILITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METASTASIS; OVARIAN CANCER CELL LINE; OVARY CANCER; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CYCLE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

AMYLOID PRECURSOR PROTEIN SECRETASES; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CXCL12; DIPEPTIDES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; RECEPTOR, NOTCH1; RECEPTORS, CXCR4; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84938881908     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2015.07.015     Document Type: Article

References (40)

1. I. Ahmad, S. Balasubramanian, C.B. Del Debbio, S. Parameswaran, A.R. Katz, C. Toris, and et al. Regulation angiogenesis by Notch signaling: implication in neovascular age-related macular degeneration Invest. Ophtalmol. Vis. Sci. 52 2011 2868 2878
2. M.V. Barbolina, M. Kim, Y. Liu, J. Shepard, A. Belmadan, R.J. Miller, and et al. Microenvironmental regulation of chemokine (C-X-C-Motif) receptor 4 in ovarian carcinoma Mol. Cancer Res. 8 2010 653 664
3. E. Bignotti, R.A. Tassi, S. Calza, A. Ravaggi, E. Bandiera, E. Rossi, and et al. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes Am. J. Obstet. Gynecol. 196 2007 e1 e11
4. S. Buonamici, T. Trimarchi, M.G. Ruocco, L. Reavie, S. Cathelin, B.G. Mar, and et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia Nature 459 2009 1000 1004
5. Cancer Genome Atlas Research Network, 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615.
6. J.H. Choi, J.T. Park, B. Davidson, P.J. Morin, IeM Shih, and T.L. Wang Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion Cancer Res. 68 2008 5716 5723
7. M. Colombo, L. Mirandola, N. Platonova, L. Apicella, A. Basile, A.J. Figueroa, and et al. Notch-directed microenvironment reprogramming in myeloma: a single path to multiple outcomes Leukemia 27 2013 1009 1018
8. M. Colombo, K. Thümmler, L. Mirandola, S. Garavelli, K. Todoerti, L. Apicella, and et al. Notch signaling drives multiple myeloma induced osteoclastogenesis Oncotarget 5 2014 10393 10406
9. M.E. Fortini Gamma-secretase-mediated proteolysis in cell-surface-receptor signalling Nat. Rev. Mol. Cell Biol. 3 2002 673 684
10. V. Galic, C.J. Shawber, C. Reeves, M. Shah, A. Murtomaki, J. Wright, and et al. NOTCH2 expression is decreased in epithelial ovarian cancer and is related to the tumor histological subtype Pathol. Discov. 1 2013 4
11. J.W. Groeneweg, R. Foster, W.B. Growdon, R.H. Verheijen, and B.R. Rueda Notch signaling in serous ovarian cancer J. Ovarian Res. 7 2014 95
12. O. Hopfer, D. Zwahlen, M.F. Fey, and S. Aebi The Notch pathway in ovarian carcinomas and adenomas Br. J. Cancer 93 2005 709 718
13. K. Hori, A. Sen, and S. Artavanis-Tsakonas Notch signaling at a glance J. Cell Sci. 126 2013 2135 2140
14. N. Hoshino, N. Katayama, T. Shibasaki, K. Ohishi, J. Nishioka, M. Masuya, and et al. A novel role for Notch ligand Delta-1 as a regulator of human Langerhans cell development from blood monocytes J. Leukoc. Biol. 78 2005 921 929
15. W. Hu, C. Lu, H.H. Dong, J. Huang, D.Y. Shen, R.L. Stone, and et al. Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer Cancer Res. 71 2011 6030 6039
16. W. Hu, T. Liu, C. Ivan, Y. Sun, J. Huang, L.S. Mangala, and et al. Notch3 pathway alterations in ovarian cancer Cancer Res. 74 2014 3282 3293
17. C. Ivan, W. Hu, J. Bottsford-Miller, B. Zand, H.J. Dalton, T. Liu, and et al. Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer Gynecol. Oncol. 128 2013 506 511
18. S. Jarriault, C. Brou, F. Logeat, E.H. Schroeter, R. Kopan, and A. Israel Signalling downstream of activated mammalian Notch Nature 377 1995 355 358
19. Y.P. Jiang, X.H. Wu, B. Shi, W.X. Wu, and G.R. Yin Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression Gynecol. Oncol. 103 2006 226 233
20. S.G. Jung, Y.D. Kwon, J.A. Song, M.J. Back, S.Y. Lee, C. Lee, and et al. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma Cancer Sci. 101 2010 1977 1983
21. V. Jurisic, T. Srdic Rajic, G. Konjevic, G. Bogdanovic, and M. Colic TNF-α induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells J. Membr. Biol. 239 2011 115 122
22. H. Kajiyama, K. Shibata, T. Mikio, K. Ino, A. Nawa, and F. Kikkawa Involvment of SDF-1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma Int. J. Cancer 122 2008 91 99
23. J.H. Kang, D.H. Lee, J.S. Lee, H.J. Kim, J.W. Shin, Y.H. Lee, and et al. Eosinophilic differentiation is promoted by blockage of Notch signaling with a gamma-secretase inhibitor Eur. J. Immunol. 35 2005 2982 2990
24. M.J. Kluk, T. Ashworth, H. Wang, B. Knoechel, E.F. Mason, E.A. Morgan, and et al. Gauging NOTCH1 activation in cancer using immunohistochemistry PLoS ONE 8 2013 e67306
25. R. Kopan, and M.X. Ilagan The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 2009 216 233
26. J.A. Ledermann, and F.A. Raja Targeted trials in ovarian cancer Gynecol. Oncol. 119 2010 151 156
27. S. Maerki, R. Ceredig, and A. Rolink Induction of chemokine receptor expression during early stage a of T cell development Immunol. Lett. 104 2006 110 117
28. L. Mirandola, L. Apicella, M. Colombo, Y. Yu, D.G. Berta, N. Platonova, and et al. Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 Leukemia 27 2013 1558 1566
29. L. Mirandola, M. Chiriva-Internati, D. Montagna, F. Locatelli, M. Zecca, M. Ranzani, and et al. Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia J. Pathol. 226 2012 713 722
30. G. Oktem, M. Sanci, A. Bilir, Y. Yildirim, S.D. Kececi, S. Ayla, and et al. Cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer Int. J. Gynecol. Cancer 22 2012 23 29
31. J.T. Park, M. Li, K. Nakayama, T.L. Mao, B. Davidson, Z. Zhang, R.J. Kurman, and et al. Notch3 gene amplification in ovarian cancer Cancer Res. 66 2006 6312 6318
32. L. Pissarra, D. Henrique, and A. Duarte Expression of hes6, a new member of the Hairy/Enhancer-of-split family, in mouse development Mech. Dev. 95 2000 275 278
33. A. Popple, L.G. Durrant, I. Spendlove, P. Rolland, I.V. Scott, S. Deen, and et al. The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer Br. J. Cancer 106 2012 1306 1313
34. S.L. Rose, M. Kunnimalaiyaan, J. Drenzek, and N. Seiler Notch 1 signaling is active in ovarian cancer Gynecol. Oncol. 117 2010 130 133
35. C.J. Scotton, J.L. Wilson, K. Scott, G. Stamp, G.D. Wilkbanks, S. Fricker, and et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer Cancer Res. 62 2002 5930 5938
36. X. Shen, S. Wang, H. Wang, M. Liang, L. Xiao, and Z. Wang The role of SDF-1/CXCR4 axis in ovarian cancer metastasis J. Huazhong. Univ. Sci. Technolog. Med. Sci. 29 2009 363 367
37. M.L. Sulils, O. Williams, T. Palomero, V. Tosello, S. Pallikuppam, P.J. Real, and et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL Blood 112 2008 733 740
38. M. Wang, J. Wang, L. Wang, L. Wu, and X. Xin Notch1 expression correlates with tumor differentiation status in ovarian carcinoma Med. Oncol. 27 2010 1329 1335
39. C.K. Williams, M. Segarra, L. Sierra Mde, R.C. Sainson, G. Tosato, and A.L. Harris Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells Cancer Res. 68 2008 1889 1895
40. B.A. Zabel, S. Lewén, R.D. Berahovich, J.C. Jaén, and T.J. Schall The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells Mol. Cancer 10 2011 73